USPTO 2015–2025 USPTO PatentsView US Corporation

Fenwal, Inc.

USPTO PatentsView assignee record - 363 granted patents across 60 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Fenwal ranks #1,171 of 49,997 tracked US assignees by granted-patent volume, with 363 patents across 60 technology areas.

#1,171
of 49,997 US assignees by volume
Top 3%
by Innovation Score (61.6/100)
15.8
avg claims per patent
+11%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1171 · US Corporation #1,171 · 363 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-MID 363 grants
  • TOP-DECILE #1,171/49,997
  • PHOTO-FINISH Ability Opto-…
  • CPC-WIDE A61M · 60 areas
  • INNOV-STRONG 61.6/100
  • CLAIMS-RICH 15.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +11% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ability Opto-electronics Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Fenwal

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Fenwal's Innovation Score is 61.6/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Fenwal's grant cadence moved

Between 2020–2024, Fenwal, Inc. received 176 grants versus 159 in 2015–2019 (+11% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2019 at 44 grants and bottomed in 2015 at 24. Lead class A61M accounts for 77.7% of the portfolio across 60 subclasses. Volume neighbours: Purdue Pharma L.P. (#1,167) and Coupang Corp. (#1,175).

Fenwal's three-year grant acceleration

From 2019–2021 to 2022–2024, Fenwal, Inc. moved from 109 to 111 grants (1.02x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,136. See the growth leaderboard.

Who files at Fenwal's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Fenwal holds 363 patents at rank #1,171, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Fenwal

By rank, the assignees closest to #1,171 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Fenwal's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Fenwal, neither rank-band nor same-CPC leaders (those blocks stay above).

Fenwal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

202530354045 20152016201720182019202020212022202320242025 28
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Fenwal, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 24 6.6%
2016 27 7.4%
2017 33 9.1%
2018 31 8.5%
2019 44 12.1%
2020 30 8.3%
2021 35 9.6%
2022 37 10.2%
2023 33 9.1%
2024 41 11.3%
2025partial year 28 7.7%

Which technologies does Fenwal, Inc. patent most?

Top 15 of 60 technology areas

Where it ranks

Overall rank by patents

#1,171

of 49,997 tracked assignees

Innovation Score

61.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Fenwal, Inc.'s patent record in context - here's where to go next.

  • Fenwal, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 77.7% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #1,171 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Fenwal, Inc. against Purdue Pharma L.P., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 61.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.